BUSINESS

Target Discovery

AI-Driven Target Discovery

Each PDO established by GBCC contains characteristic information such as genome analysis and drug reactivity. Our AI algorithms integrate three-dimensional information to discover novel anti-cancer targets.

Discovery Validation
  • PDO-based genomic data
  • Development of
    AI target discovery algorithms
  • Comparative analysis of
    integrated genomic data
  • Experimental verification

GBCC's AI target discovery platform adopts an analysis method that applies step by step various analysis algorithms and statistical filtering
to discover highly promising anti-cancer targets from hard to collect genetic information from patients and PDOs.

The novel targets are verified through experimental analysis using our PDO-based CRISPR systems.

  • Candidate target
  • Target verification using CRISRR systems
  • Target validation and selection